Cargando…
Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896766/ https://www.ncbi.nlm.nih.gov/pubmed/35250270 http://dx.doi.org/10.2147/NDT.S361484 |
| _version_ | 1784663237930778624 |
|---|---|
| author | Brück, Chiara C |
| author_facet | Brück, Chiara C |
| author_sort | Brück, Chiara C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8896766 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88967662022-03-05 Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter] Brück, Chiara C Neuropsychiatr Dis Treat Letter Dove 2022-02-28 /pmc/articles/PMC8896766/ /pubmed/35250270 http://dx.doi.org/10.2147/NDT.S361484 Text en © 2022 Brück. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Brück, Chiara C Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter] |
| title | Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter] |
| title_full | Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter] |
| title_fullStr | Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter] |
| title_full_unstemmed | Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter] |
| title_short | Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter] |
| title_sort | letter to the editor regarding “fluoxetine may enhance vegf, bdnf and cognition in patients with vascular cognitive impairment no dementia: an open-label randomized clinical study” [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896766/ https://www.ncbi.nlm.nih.gov/pubmed/35250270 http://dx.doi.org/10.2147/NDT.S361484 |
| work_keys_str_mv | AT bruckchiarac lettertotheeditorregardingfluoxetinemayenhancevegfbdnfandcognitioninpatientswithvascularcognitiveimpairmentnodementiaanopenlabelrandomizedclinicalstudyletter |